In patients with HFpEF and obesity, symptom reduction and weight loss provided by semaglutide extends to those with diabetes, suggest new data from the STEP-HFpEF DM trial.
American College of Cardiology ACC 24 Late-breaking Science and Guidelines Session Summary dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.
The findings challenge pacing recommendations in HFpEF with chronotropic incompetence and should highlight the disorder s systemic nature, say observers.
The American College of Cardiology (ACC) has announced five Late-Breaking Clinical Trial Sessions, two Late-Breaking Clinical Trial Deep Dive Sessions, and three Featured Clinical Research sessions to be presented during its annual scientific session, “ACC with WCC,” or ACC.23/WCC to be held March 4-6 in New Orleans, LA.
The multiverse exists as the ACC offers a traditional in-person meeting spanning all of cardiology paired with what could be a lasting legacy of the pandemic, a robust, parallel virtual experience.